Caregen Co.Ltd (214370.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7214370009
Caregen Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 82.59 bn KRW | 72.81 bn KRW |
| Gross profit | 55.32 bn KRW | 52.24 bn KRW |
| Operating income | 34.60 bn KRW | 20.40 bn KRW |
| EBIT | 34.25 bn KRW | 20.40 bn KRW |
| Net income | 32.31 bn KRW | 20.10 bn KRW |
| Diluted EPS – continuing operations | 659.54 KRW | 411.26 KRW |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Caregen Co.Ltd
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names. The company's products are used in anti-aging, anti-pigmentation, anti-hair loss, anti-inflammation, and other skin troubles, as well as blood sugar control, baby skin care, and acute muscle pain applications. In addition, its products in pipeline include pharmaceuticals in the areas of wet and dry macular degeneration, diabetic retinopathy, cataract, hyperhidrosis, pain relief, obesity, psoriasis, scar, arthritis, rhinitis, anti-virus, and Covid-19 treatment; and medical devices for face beauty treatment, scalp and hair improvement, body care, arthritis, and new face beauty treatment. Further, the company is developing cosmeceutical produts for anti-wrinkle, whitening, sun block, atopic dermatitis care, particulate matter inhibition, double chin removal, dark circle care, reduction of cellulite, sebum secretion control, and pore tightening applications; and food supplements in the areas of hangover cure, cholesterol control, and body fat lipolysis. Caregen Co., Ltd. was founded in 2001 and is based in Anyang-si, South Korea.
More stocks
- ZHEJIANG ASIA-PACIFIC MECHANICAL & ELECTRONIC CO LTD (002284.SZ)
- Beijing Jingyuntong Technology Co Ltd (601908.SS)
- MICROALLIANCE GROUP INC. (MALG)
- Hangzhou Heatwell Electric Heating Technology Co., Ltd. (603075.SS)
- Shaanxi Zhongtian Rocket Technology (003009.SZ)
- Neuberger Berman Next Generation Connectivity Fund Inc (NBXG)
- ICHOR HOLDINGS, LTD. (ICHR)
- Altareit SCA (AREIT.PA)
- Ningbo Kangqiang Electronics Co Ltd (002119.SZ)
- Saturn Oil & Gas Inc (SOIL.TO)
- UNITIL CORP (UTL)
- Dauch Corp (DCH)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.